Home > Healthcare > Medical Devices > Implantable Devices > Vascular Graft Market
Vascular Graft Market size was valued at more than USD 2.5 billion in 2022. Driven by technological improvements in vascular grafting, the industry is expected to grow at over 8% CAGR between 2023 and 2032.
The growing geriatric population across the globe is projected to boost market progress. Numerous age-related ailments, including cardiovascular disease and hypertension, are closely correlated with increasing age. Elderly people are also more prone to suffer from abdominal aortic aneurysms (AAA).
Technological advancements in developed countries are another substantial factor driving the vascular graft market expansion. The growing conventional grafts failure has encouraged developments in minimally invasive, biomaterial-based vascular grafts. Additionally, leading companies are focusing on human-like vascular grafts vessels that are thrombus-resistant, biocompatible, and hemocompatible.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Vascular Graft Market Size in 2022: | USD 2.5 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 8% |
2032 Value Projection: | USD 6.5 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 154 |
Tables, Charts & Figures: | 218 |
Segments covered: | Raw material, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
The lack of skilled personnel in developing countries is a major factor restraining the market development. The vascular grafting sector is consistently struggling with a lack of skilled professionals despite the fact that they are required to ensure effective and efficient procedural success. According to the Cardiologists Society of India (CSI), there were only 5500 cardiologists practicing in India in 2021. A country with 1.3 billion people, India only has one cardiologist for every 30,000 people.
With respect to raw material, the vascular graft market is divided into biosynthetic grafts, EPTFE grafts, polyester grafts, and polyurethane grafts. The EPTFE grafts segment held over 28% market share in 2022. Due to their higher porosity and greater pliability, these grafts are highly preferred for hemodialysis access. Furthermore, the advancements in EPTFE graft technology are also shaping the segment outlook.
Global Vascular Graft Market Share, By End-use, 2022 (%) |
|
---|---|
Segment |
Global market share (%), 2022 |
Hospitals |
62.30% |
Ambulatory surgical centers |
25.90% |
Others |
11.70% |
Based on end-use, the vascular graft market is segregated into ambulatory surgical centers, hospitals, and others. The hospitals segment clocked more than USD 1.5 billion in valuation in 2022. The improved patient management and favorable hospital reimbursement policies are set to boost hospital revenue share through the forecast period. To cite an instance, the Centers for Medicare & Medicaid Service’s hospital-acquired condition reduction program supports hospitals to improve patient safety and manage implications associated with health care at hospitals.
In terms of application, the vascular graft market is classified into endovascular aneurysm repair, peripheral vascular repair, and hemodialysis access. The market size from the endovascular aneurysm repair segment was recorded at more than USD 1 billion in 2022. Endovascular aneurysm repair (EVAR) is gaining popularity due to its low cost, short hospital stays, low risks, and growing adoption rate of minimally invasive surgical procedures. According to a decision aid study, patients preferred the EVAR procedure over open repair due to its low perioperative mortality and less invasive nature.
Asia Pacific vascular graft market is slated to progress at over 9% CAGR from 2023 to 2032. The region's growing geriatric population has augmented the demand for minimally invasive vascular surgeries, boosting the regional market statistics. As per the Economic and Social Commission for Asia and the Pacific (ESCAP) survey report, there are over 630 million people aged above 60, which is estimated to reach 1.3 billion by 2050 in the Asia Pacific.
are some of the key market players. These firms majorly focus on expanding the customer reach and accelerating production capacity to boost their market position.
The global COVID-19 outbreak had impacted the vascular graft industry negatively in 2020, as a result of the rising coronavirus cases which resulted in the delay of several surgical procedures. However, with the effects of the pandemic fading and resumption in surgical procedures, key market players have been investing in vascular graft production in line with the surging demand for vascular grafts.
The vascular graft market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments: Click here to Buy Section of this Report
By Raw Material
By Application
By End-use
The above information is provided for the following regions and countries: